Related Experiment Video
Updated: Jan 27, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy
Lian-Hua Fu1,2, Chao Qi1, Yan-Ru Hu1
1Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, International Cancer Center, Laboratory of Evolutionary Theranostics, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, 518060, China.
Abstract:
Over the past 3 years, glucose oxidase (GOx) has aroused great research interest in the context of cancer treatment due to its inherent biocompatibility and biodegradability, and its unique catalytic properties against β-d-glucose. GOx can effectively catalyze the oxidation of glucose into gluconic acid and hydrogen peroxide. This process depletes oxygen levels, resulting in elevated acidity, hypoxia, and oxidative stress in the tumor microenvironment. All of these changes can be readily harnessed to develop a multimodal synergistic cancer therapy by combining GOx with other therapeutic approaches. Herein, the representative studies of GOx-instructed multimodal synergistic cancer therapy are introduced, and their synergistic mechanisms are discussed systematically. The current challenges and future prospects to advance the development of GOx-based nanomedicines in this cutting-edge research area are highlighted.
Insights
Glucose oxidase (GOx) shows promise for cancer therapy by altering the tumor microenvironment. Combining GOx with other treatments enhances synergistic effects for multimodal cancer treatment strategies.
Area of Science:
- Biochemistry
- Nanomedicine
- Cancer Therapy
Background:
- Glucose oxidase (GOx) is biocompatible and biodegradable.
- GOx catalyzes glucose oxidation, producing gluconic acid and hydrogen peroxide.
- This process impacts the tumor microenvironment by reducing oxygen and increasing acidity.
Purpose of the Study:
- To review studies on GOx-instructed multimodal synergistic cancer therapy.
- To discuss the synergistic mechanisms of GOx-based therapies.
- To highlight challenges and future prospects for GOx nanomedicines.
Main Methods:
- Systematic review of representative studies.
- Analysis of GOx-instructed multimodal synergistic cancer therapy.
- Discussion of synergistic mechanisms and challenges.
Main Results:
- GOx triggers tumor hypoxia, acidity, and oxidative stress.
- These changes facilitate multimodal synergistic cancer therapy.
- GOx-based nanomedicines offer potential for advanced cancer treatment.
Conclusions:
- GOx is a promising agent for multimodal cancer therapy.
- Further development of GOx-based nanomedicines is warranted.
- GOx-instructed therapies represent a cutting-edge research area.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Gene Therapy
Glucose Absorption Into the Small Intestine

